Basic information
Biomarker: Asparaginase-like protein 1
Histology type: endometrial carcinoma
Cohort characteristics
Country: Norway
Region: Bergen
Study type: prospectively study
Followed up time :
Subgroup 1 name : High
Subgroup 1 number: 539
Subgroup 2 name: Low
Subgroup 2 number: 84
Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
---|---|---|---|---|---|---|---|---|
1051 | primary endometrial carcinomas | 782 | precursor lesions | 90 | metastases | 179 | primary tumors mRNA investigated | 237 |
Sample information
Conclusion: Asparaginase-like protein 1 is an independent prognostic marker in primary endometrial cancer, and is frequently lost in metastatic lesions.
Sample type : tissue
Sample method: immunohistochemistry
Expression pattern : loss expression
Expression elevation: A staining index (SI) was calculated for each patient based on all three cylinders by multiplying staining intensity (range 0–3) and area of positive stained tumor cells (1 ≤ 10%, 2 = 10–50%, 3 ≥ 50%) as previously reported. The upper three quartiles were combined based on similarities in survival, and defined as “ASRGL1 high”. The lower quartile was defined as “ASRGL1 low”, corresponding to SI: 0–2 (HPA029725) or SI:0–1 (AMAb90907).
Disease information
Statictics: cutoff<66;cutoff>66
Cohort age: 405;377
Subgroup 1 age: 341;275
Subgroup 2 age: 64;102
Related information
Funtion Uniprot: Has both L-asparaginase and beta-aspartyl peptidase activity. May be involved in the production of L-aspartate, which can act as an excitatory neurotransmitter in some brain regions. Is highly active with L-Asp beta-methyl ester. Besides, has catalytic activity toward beta-aspartyl dipeptides and their methyl esters, including beta-L-Asp-L-Phe, beta-L-Asp-L-Phe methyl ester (aspartame), beta-L-Asp-L-Ala, beta-L-Asp-L-Leu and beta-L-Asp-L-Lys. Does not have aspartylglucosaminidase activity and is inactive toward GlcNAc-L-Asn. Likewise, has no activity toward glutamine.
UniProt ID: Q7L266
UniProt Link: https://www.uniprot.org/uniprotkb/Q7L266/entry
Molecular function from UniProt:
Tissue specificity from UniProt: Expressed in brain, kidney, testis and tissues of the gastrointestinal tract. Present in sperm (at protein level). Over-expressed in uterine, mammary, prostatic and ovarian carcinoma.
Subcellular UniProt: #Cytoplasm
Alternative name from UniProt:
Cleaved: Cleaved into 2 chains:Isoaspartyl peptidase/L-asparaginase alpha chain Isoaspartyl peptidase/L-asparaginase beta chain
Catalytic activity: H2O + L-asparagine = L-aspartate + NH4+
Gene name from HGNC: ASRGL1 (ALP, ALP1, FLJ22316)
Induction: By 5-alpha-di-hydrotestosterone and progesterone.
HPA link: https://www.proteinatlas.org/ENSG00000162174-ASRGL1
Tissue specificity RNA from HPA: Tissue enhanced (brain, cervix, testis)
Tissue expression from HPA: Cytoplasmic expression most abundant in seminiferous ducts and glandular cells of female genital tract.
Subcellular summary HPA Located in Nucleoplasm, Microtubules, Cytokinetic bridge (Single cell variability)
Cancer prognostic summary HPA Prognostic marker in renal cancer (favorable), endometrial cancer (favorable), colorectal cancer (favorable) and liver cancer (unfavorable)
Pathology link: https://www.proteinatlas.org/ENSG00000162174-ASRGL1/pathology
Pathology endo: https://www.proteinatlas.org/ENSG00000162174-ASRGL1/pathology/endometrial+cancer
HGNC ID: HGNC:16448
HGNC link: https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:16448